CIK 0001285819
- Non-accelerated filer
- Smaller reporting company
OMEROS CORP
Sign in to watch- Ticker
- OMER
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- WA
- Entity type
- Operating
- EIN
- 911663741
- Phone
- +1 206-676-5000
- Business address
- 201 ELLIOTT AVENUE WEST, SEATTLE, WA, 98119
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,837,566
- in 4 filings, $626K under 10b5-1 plans
Net −$1,837,566. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 78 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-06-05 | Bumol Thomas F. Director | Grant or award · Stock Option (Right to Buy) | +7,500 | 7,500 | ||
| 2020-06-05 | HANISH ARNOLD C Director | Grant or award · Stock Option (Right to Buy) | +7,500 | 7,500 | ||
| 2020-05-13 | Cable Thomas J. Director | Exercise or conversion | +5,000 | $5.92 | $30K | 40,067 |
| 2020-05-13 | Cable Thomas J. Director | Sale | −5,000 | $14.40 | $72K | 35,067 |
| 2020-05-13 | Cable Thomas J. Director | Exercise or conversion · Stock Option (Right to Buy) | −5,000 | |||
| 2020-03-13 | Hood Leroy E. MD PhD Director | Exercise or conversion | +5,000 | $5.92 | $30K | 69,390 |
| 2020-03-13 | Hood Leroy E. MD PhD Director | Exercise or conversion · Stock Option (Right to Buy) | −5,000 | 0 | ||
| 2020-03-01 | Demopulos Gregory A MD CHIARMAN, CEO & PRESIDENT | Grant or award · Stock Option (right to buy) | +450,000 | 450,000 | ||
| 2020-03-01 | JACOBSEN MICHAEL A VP FINANCE AND CAO | Grant or award · Stock Option (right to buy) | +70,000 | 70,000 | ||
| 2020-03-01 | Cancelmo Peter B VP, GEN. COUNSEL & CORP. SEC. | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2020-02-10 | Zumwalt Kurt Director | Grant or award · Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2020-02-10 | Zumwalt Kurt Director | Grant or award · Stock Option (right to buy) | +11,750 | 11,750 | ||
| 2019-12-14 | Hood Leroy E. MD PhD Director | Exercise or conversion | +10,000 | $7.56 | $76K | 64,390 |
| 2019-12-14 | Hood Leroy E. MD PhD Director | Exercise or conversion · Stock Option (Right to Buy) | −10,000 | 0 | ||
| 2019-12-14 | Demopulos Peter A MD Director | Exercise or conversion | +3,334 | $7.56 | $25K | 188,516 |
| 2019-12-14 | Demopulos Peter A MD Director | Exercise or conversion · Stock Option (Right to Buy) | −3,334 | 0 | ||
| 2019-12-03 | Cable Thomas J. Director | Exercise or conversion | +10,000 | $7.56 | $76K | 45,067 |
| 2019-12-03 | Cable Thomas J. Director | Sale | −10,000 | $14.41 | $144K | 35,067 |
| 2019-12-03 | Cable Thomas J. Director | Exercise or conversion · Stock Option (Right to Buy) | −10,000 | 0 | ||
| 2019-10-14 | Cable Thomas J. Director | Sale | −5,000 | $15.12 | $76K | 35,067 |
Page 10 of 20 · 391 trades